Publication: Precision medicine in Thailand
7
Issued Date
2019-06-01
Resource Type
ISSN
15524876
15524868
15524868
Other identifier(s)
2-s2.0-85063092252
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. Vol.181, No.2 (2019), 245-253
Suggested Citation
Vorasuk Shotelersuk, Sissades Tongsima, Manop Pithukpakorn, Jakris Eu-ahsunthornwattana, Surakameth Mahasirimongkol Precision medicine in Thailand. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. Vol.181, No.2 (2019), 245-253. doi:10.1002/ajmg.c.31694 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/50170
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Precision medicine in Thailand
Other Contributor(s)
Chulalongkorn University
King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Thailand Ministry of Public Health
Thailand National Center for Genetic Engineering and Biotechnology
Faculty of Medicine, Siriraj Hospital, Mahidol University
King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Thailand Ministry of Public Health
Thailand National Center for Genetic Engineering and Biotechnology
Faculty of Medicine, Siriraj Hospital, Mahidol University
Abstract
© 2019 Wiley Periodicals, Inc. Extraordinary advances in high throughput next generation sequencing (NGS) technology and bioinformatics are the main thrust that transforms the current state of healthcare into the era of precision medicine where clinical practice takes individual variability into account. Here, we summarize the current status of the infrastructure we have and the adoption of precision medicine in Thailand in four spheres: rare diseases, oncology, pharmacogenomics, and noncommunicable diseases. Moreover, we provide our perspectives to the future of precision medicine in Thailand, especially the manpower and ethical, legal, and social issues. We believe that with decreasing costs of NGS, increasing ability to interpret the genomic data, a greater number of actionable and available treatments, implementation of precision medicine at the public health level is not a matter of if but when.